Skip to main content
Clinical Trials/TCTR20220715003
TCTR20220715003
Unknown
Phase 4

Efficacy of single buccal infiltration of 4% articaine with 1:100,000 epinephrine and 2% mepivacaine with 1:100,000 epinephrine during maxillary premolar teeth extraction: a Double-blined randomized controlled trial

Department of Oral and Maxillofacial Surgery, Faculty of Dentistry , Chiangmai university0 sites20 target enrollmentJuly 15, 2022

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
The pain during injecting local anesthesia by palatal infiltration
Sponsor
Department of Oral and Maxillofacial Surgery, Faculty of Dentistry , Chiangmai university
Enrollment
20
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
July 15, 2022
End Date
February 22, 2023
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
Department of Oral and Maxillofacial Surgery, Faculty of Dentistry , Chiangmai university

Eligibility Criteria

Inclusion Criteria

  • 1\. Participants who have been diagnosed with premolar teeth extraction in the upper jaw on both sides
  • 2\. No gender and age limit
  • 3\. Be in good health or AHA Classifications I and II
  • 4\. Not during the first or third trimester of pregnancy or breast\-feeding.
  • 5\. Able to receive treatment and follow up at specified intervals

Exclusion Criteria

  • 1\. Participants who have any hypersensitivity to amide local anesthetics or components of anesthetics.
  • 2\. the premolar teeth have pathological signs and pain or there are periapical lesions.
  • 3\. Participants have any soft tissue infection.
  • 4\. Participants who received NSAIDs and acetaminophen 24 hours before the study.

Outcomes

Primary Outcomes

Not specified

Similar Trials